Science at the service of urgent global issues

We’re proud to be part of The Next Frontier series, which explores how innovations are creating a healthier and more sustainable future for everyone. This film was produced for us by BBC StoryWorks Commercial Productions.

As part of the project, Krka’s story addresses the transformative breakthroughs in the treatment of cardiovascular diseases, which remain one of the leading causes of mortality globally. Additionally, these diseases experience a relatively high level of non-adherence often due to complex treatment regimens.

Single-pill combinations (SPCs) combine several active substances in a single tablet. As such, they simplify treatment regimens and consequently lead to better treatment outcomes. This is why we consider more than 150 Krka’s SPCs as some of our most important innovative solutions.

Among them, Krka’s portfolio includes 110 cardiology SPCs, backed by over 35 years of experience. This way, we are committed to delivering accessible, high-quality treatments that make a difference and improve the outcomes.

Among them Krka’s portfolio comprises 110 cardiology SPCs with over 35 years of experiences. This way, we are committed to delivering accessible, high-quality treatments that make a difference and improve the outcomes.